A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes-Reference-Cited by-同舟云学术

A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes

Published:2019-02-20 Issue:5 Volume:47 Page:484-492
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Riccardi Keith A.,Tess David A.,Lin Jian,Patel Roshan,Ryu Sangwoo,Atkinson Karen,Di Li,Li Rui

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference66 articles.

1. Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects;Abel;Br J Clin Pharmacol,2008

2. THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES

3. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile;Balani;Drug Metab Dispos,1997

4. An overview of clinical pharmacology of Ibuprofen;Bushra;Oman Med J,2010

5. Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate;Caldwell;Br J Clin Pharmacol,1986

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors;Clinical Pharmacokinetics;2024-08

2. A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter fd in Physiologically Based Pharmacokinetics;Journal of Pharmaceutical Sciences;2024-01

3. Blood Flow Distribution and Membrane Transporters as Determinant Factors of Tissue Drug Concentration;ADME Processes in Pharmaceutical Sciences;2024

4. Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics‐Informed Relative Expression Factor Approach;Clinical Pharmacology & Therapeutics;2023-12-18

5. Use of Human Intestinal and Hepatic Tissue Fractions and Microbiome as Models in Assessment of Drug Metabolism and its Impact on Oral Bioavailability;Oral Bioavailability and Drug Delivery;2023-10-10